Evidence map›Paper›PMID 42661104›Full record

ArticleMolecular neurobiology2026

Chlorogenic Acid Fails to Confer Neuroprotection in a Chronic Mouse Model of Parkinson's Disease.

Akshaya Rajan, Surya Prakash, Devendra Singh, Poonam Thakur

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Akshaya RajanSchool of Biology, Indian Institute of Science Education and Research (IISER), Thiruvananthapuram, Kerala, 695551, India.
Surya PrakashSchool of Biology, Indian Institute of Science Education and Research (IISER), Thiruvananthapuram, Kerala, 695551, India.
Devendra SinghSchool of Biology, Indian Institute of Science Education and Research (IISER), Thiruvananthapuram, Kerala, 695551, India.
Poonam ThakurSchool of Biology, Indian Institute of Science Education and Research (IISER), Thiruvananthapuram, Kerala, 695551, India. poonam@iisertvm.ac.in.

Funding

Cure Parkinson's Trust PT01Department of Biotechnology, Government of India DBT/2021-22/IISER-TVM/1748Science and Engineering Research Board SRG/2021/000981Wellcome Trust DBT India Alliance IA/E/17/1/503664
6 · The paper itself

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by α-synuclein (α-Syn) aggregation, dopaminergic neuronal loss, and chronic neuroinflammation. Chlorogenic acid (CA), a dietary polyphenol abundant in coffee, exhibits antioxidant and anti-inflammatory properties and has shown neuroprotective effects in acute toxin-based PD models. However, its efficacy in chronic, α-Syn-driven PD models remains unclear. Here, we evaluated the therapeutic potential of CA using an α-Syn-based in vitro system and a chronic α-Syn overexpression mouse model that recapitulates key pathological features of human PD. In vitro, CA significantly improved cell viability, reduced α-Syn aggregation, and attenuated H

Indexed as

Chlorogenic AcidNeuroprotectionNeuroprotective AgentsParkinson Diseasealpha-SynucleinAnimalsApoptosisChronic DiseaseDisease Models, AnimalDopaminergic NeuronsFemaleHumansMaleMiceMice, Inbred C57BLMice, Transgenicalpha-SynucleinChlorogenic AcidNeuroprotective AgentsNeurodegenerationNeuroinflammationNeuroprotectionα-Synuclein

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.